Voclosporin: a novel calcineurin inhibitor for the treatment of lupus nephritis.
Saved in:
| Title: | Voclosporin: a novel calcineurin inhibitor for the treatment of lupus nephritis. |
|---|---|
| Authors: | van Gelder T; Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, The Netherlands., Lerma E; Section of Nephrology, University of Illinois at Chicago College of Medicine/Advocate Christ Medical Center, Chicago, IL, USA., Engelke K; Department of Research, Aurinia Pharmaceuticals Inc, Victoria, British Columbia, Canada., Huizinga RB; Department of Research, Aurinia Pharmaceuticals Inc, Victoria, British Columbia, Canada. |
| Source: | Expert review of clinical pharmacology [Expert Rev Clin Pharmacol] 2022 May; Vol. 15 (5), pp. 515-529. Date of Electronic Publication: 2022 Jul 11. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 101278296 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1751-2441 (Electronic) Linking ISSN: 17512433 NLM ISO Abbreviation: Expert Rev Clin Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35763288 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Voclosporin: a novel calcineurin inhibitor for the treatment of lupus nephritis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22van+Gelder+T%22">van Gelder T</searchLink>; Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Lerma+E%22">Lerma E</searchLink>; Section of Nephrology, University of Illinois at Chicago College of Medicine/Advocate Christ Medical Center, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Engelke+K%22">Engelke K</searchLink>; Department of Research, Aurinia Pharmaceuticals Inc, Victoria, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22Huizinga+RB%22">Huizinga RB</searchLink>; Department of Research, Aurinia Pharmaceuticals Inc, Victoria, British Columbia, Canada. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101278296%22">Expert review of clinical pharmacology</searchLink> [Expert Rev Clin Pharmacol] 2022 May; Vol. 15 (5), pp. 515-529. <i>Date of Electronic Publication: </i>2022 Jul 11. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101278296 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1751-2441 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217512433%22">17512433 </searchLink><i>NLM ISO Abbreviation: </i>Expert Rev Clin Pharmacol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35763288 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/17512433.2022.2092470 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 515 Titles: – TitleFull: Voclosporin: a novel calcineurin inhibitor for the treatment of lupus nephritis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: van Gelder T – PersonEntity: Name: NameFull: Lerma E – PersonEntity: Name: NameFull: Engelke K – PersonEntity: Name: NameFull: Huizinga RB IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2022 May Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1751-2441 Numbering: – Type: volume Value: 15 – Type: issue Value: 5 Titles: – TitleFull: Expert review of clinical pharmacology Type: main |
| ResultId | 1 |